Bisindolylmaleimide I (GF109203X)

Bisindolylmaleimide I (GF109203X) is an inhibitor of PKC used in studies of MAPK / ERK Signaling and TGF-beta / Smad Signaling. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and Smad-mediated transcription, differentiation, and fibrotic signaling in cancer, cell signaling, and developmental biology models.

By inhibiting PKC, Bisindolylmaleimide I (GF109203X) can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and Smad-mediated transcription, differentiation, and fibrotic signaling. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and developmental biology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving PKC
• Pathway perturbation studies connected to MAPK / ERK Signaling and TGF-beta / Smad Signaling
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, Bisindolylmaleimide I (GF109203X) is appropriate when a defined chemical perturbant is needed to connect PKC with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and developmental biology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.